Co-prescription of retapamulin and topical mupirocin

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

ImpetigoSkin Infections, Bacterial

Unknown Phase

EU PV for Retapamulin-Prescribing

CompletedNCT01153828

GlaxoSmithKlineImpetigo

Start: 2008-11-30End: 2012-08-31Updated: 2013-06-10

United States Pharmacovigilence Retapamulin-Prescribing

CompletedNCT01153880

GlaxoSmithKlineSkin Infections, Bacterial

Start: 2008-12-31End: 2012-08-31Updated: 2013-06-10